Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loading

Journal of Cerebral Blood Flow and Metabolism

Volumn 35, Issue 8, 2015, Pages 1380-1385

  Ishibashi, Kenji ^a   Kawasaki, Keiichi ^a   Ishiwata, Kiichi ^a   Ishii, Kenji ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

15O H2O Alzheimer's disease; 18F FDG; glucose; insulin

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; OXYGEN 15; WATER; GLUCOSE BLOOD LEVEL; OXYGEN; RADIOPHARMACEUTICAL AGENT;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; DRUG UPTAKE; FEMALE; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISOTOPE LABELING; LATERAL PARIETAL CORTEX; MALE; NORMAL HUMAN; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY; YOUNG ADULT; BLOOD; CLINICAL TRIAL; METABOLISM; PROCEDURES; RADIOGRAPHY;

ADULT; ALZHEIMER DISEASE; BLOOD GLUCOSE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OXYGEN ISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84938738991     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.127     Document Type: Article

References (42)

1. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388
2. Wang GJ, Volkow ND, Wolf AP, Brodie JD, Hitzemann RJ. Intersubject variability of brain glucose metabolic measurements in young normal males. J Nucl Med 1994; 35: 1457-1466
3. Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz HG et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. NeuroImage 2009; 44: 43-50
4. Suhonen-Polvi H, Ruotsalainen U, Kinnala A, Bergman J, Haaparanta M, Teras M et al. FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization. J Nucl Med 1995; 36: 1249-1254
5. Wienhard K. Measurement of glucose consumption using [(18)F]fluorodeoxyglucose. Methods 2002; 27: 218-225
6. Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18 F]fluorodeoxyglucose. J Comput Assist Tomogr 1983; 7: 590-598
7. Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS et al. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). NeuroImage 2009; 45: 1107-1116
8. Kawasaki K, Ishii K, Saito Y, Oda K, Kimura Y, Ishiwata K. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Ann Nucl Med 2008; 22: 191-200
9. Burns CM, Chen K, Kaszniak AW, Lee W, Alexander GE, Bandy D et al. Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology 2013; 80: 1557-1564
10. Ishibashi K, Miura Y, Oda K, Ishiwata K, Ishii K. Alzheimer's disease-like pattern of (18)F-FDG uptake during a hyperglycemic state and negative (11)C-PiB binding in a patient with mild cognitive impairment. J Alzheimer's Dis 2014; 42: 385-389
11. Ishibashi K, Onishi A, Fujiwara Y, Ishiwata K, Ishii K. Relationship between Alzheimer disease-like pattern of 18 F-FDG and fasting plasma glucose levels in cognitively normal volunteers. J Nucl Med 2015; 56: 229-233
12. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med 2001; 15: 85-92
13. Gray SM, Meijer RI, Barrett EJ. Insulin regulates brain function, but how does it get there?. Diabetes 2014; 63: 3992-3997
14. Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 2010; 75: 764-770
15. Raichle ME, Martin WR, Herscovitch P, Mintun MA, Markham J. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. J Nucl Med 1983; 24: 790-798
16. Poline JB, Vandenberghe R, Holmes AP, Friston KJ, Frackowiak RS. Reproducibility of PET activation studies: lessons from a multi-center European experiment. EU concerted action on functional imaging. NeuroImage 1996; 4: 34-54
17. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 280-292
18. Binnewijzend MA, Kuijer JP, Benedictus MR, Van Der Flier WM, Wink AM, Wattjes MP et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013; 267: 221-230
19. Orzi F, Lucignani G, Dow-Edwards D, Namba H, Nehlig A, Patlak CS et al. Local cerebral glucose utilization in controlled graded levels of hyperglycemia in the conscious rat. J Cereb Blood Flow Metab 1988; 8: 346-356
20. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992; 183: 643-647
21. Hara T, Higashi T, Nakamoto Y, Suga T, Saga T, Ishimori T et al. Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging?. Ann Nucl Med 2009; 23: 657-669
22. Yamada K, Endo S, Fukuda H, Abe Y, Yoshioka S, Itoh M et al. Experimental studies on myocardial glucose metabolism of rats with 18 F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 1985; 10: 341-345
23. Marian T, Balkay L, Fekete I, Lengyel Z, Veress G, Esik O et al. Hypoglycemia activates compensatory mechanism of glucose metabolism of brain. Acta Biol Hung 2001; 52: 35-45
24. Brondsted HE, Gjedde A. Glucose phosphorylation rate in rat parietal cortex during normoglycemia, hypoglycemia, acute hyperglycemia, and in diabetesprone rats. Acta Neurol Scand 1990; 81: 233-236
25. Duckrow RB, Bryan RM, Jr. Regional cerebral glucose utilization during hyperglycemia. J Neurochem 1987; 48: 989-993
26. Hasselbalch SG, Knudsen GM, Capaldo B, Postiglione A, Paulson OB. Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. J Clin Endocrinol Metab 2001; 86: 1986-1990
27. Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 1987; 18: 52-58
28. Harik SI, LaManna JC. Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia. J Neurochem 1988; 51: 1924-1929
29. Knudsen GM, Tedeschi E, Jakobsen J. The influence of haematocrit and blood glucose on cerebral blood flow in normal and in diabetic rats. Neuroreport 1992; 3: 987-989
30. Cambien F, Warnet JM, Eschwege E, Jacqueson A, Richard JL, Rosselin G. Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships?. Arteriosclerosis 1987; 7: 197-202
31. Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol 1999; 68: 179-186
32. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diab Care 2004; 27: 1487-1495
33. Grillo CA, Piroli GG, Hendry RM, Reagan LP. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res 2009; 1296: 35-45
34. Lucignani G, Namba H, Nehlig A, Porrino LJ, Kennedy C, Sokoloff L. Effects of insulin on local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 1987; 7: 309-314
35. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 2011; 68: 51-57
36. Anticevic A, Cole MW, Murray JD, Corlett PR, Wang XJ, Krystal JH. The role of default network deactivation in cognition and disease. Trends Cogn Sci 2012; 16: 584-592
37. Fransson P, Marrelec G. The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: Evidence from a partial correlation network analysis. NeuroImage 2008; 42: 1178-1184
38. Utevsky AV, Smith DV, Huettel SA. Precuneus is a functional core of the defaultmode network. J Neurosci 2014; 34: 932-940
39. Cavanna AE, Trimble MRThe precuneus: a review of its functional anatomy and behavioural correlatesBrain 2006; 129: 564-583
40. Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009; 63: 178-188
41. Wang L, Brier MR, Snyder AZ, Thomas JB, Fagan AM, Xiong C et al. Cerebrospinal fluid Abeta42, phosphorylated Tau181, and resting-state functional connectivity. JAMA Neurol 2013; 70: 1242-1248
42. Musen G, Jacobson AM, Bolo NR, Simonson DC, Shenton ME, McCartney RL et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 2012; 61: 2375-2379